| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0005 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0006 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0006 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0006 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0006 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0006 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0006 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.0007 |